These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9795194)

  • 61. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in foetal rats by maternal cholestyramine feeding.
    Haave NC; Innis SM
    J Dev Physiol; 1988 Jun; 10(3):247-55. PubMed ID: 3063740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis.
    Pill J; Witte EC; Schmidt FH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):552-6. PubMed ID: 2392158
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol.
    Ito T; Kawata S; Imai Y; Kakimoto H; Trzaskos JM; Matsuzawa Y
    Gastroenterology; 1996 May; 110(5):1619-27. PubMed ID: 8613070
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of age and cholestyramine feeding on rat liver 3-hydroxy-3-methyl glutaryl CoA reductase, sterol carrier protein 1 and sterol carrier protein 2 activities.
    Morin RJ; Brun MJ; Srikantaiah MV
    Lipids; 1982 Jul; 17(7):507-10. PubMed ID: 7121212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans.
    Björkhem I; Reihnér E; Angelin B; Ewerth S; Akerlund JE; Einarsson K
    J Lipid Res; 1987 Aug; 28(8):889-94. PubMed ID: 3668387
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver.
    Björkhem I; Miettinen T; Reihnér E; Ewerth S; Angelin B; Einarsson K
    J Lipid Res; 1987 Oct; 28(10):1137-43. PubMed ID: 3681138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in the human gastrointestinal tract.
    Gebhard RL; Stone BG; Prigge WF
    J Lipid Res; 1985 Jan; 26(1):47-53. PubMed ID: 3973513
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 12 alpha-hydroxylase activity in human liver and its relation to cholesterol 7 alpha-hydroxylase activity.
    Einarsson K; Akerlund JE; Reihnér E; Björkhem I
    J Lipid Res; 1992 Nov; 33(11):1591-5. PubMed ID: 1464742
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Occurrence of isomeric dehydrocholesterols in human plasma.
    Axelson M
    J Lipid Res; 1991 Sep; 32(9):1441-8. PubMed ID: 1753214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in a virilizing adrenal carcinoma.
    Lehoux JG; Kandalaft N; Belisle S; Bellabarba D; Benard B; Lefebvre A
    J Steroid Biochem; 1984 Oct; 21(4):329-42. PubMed ID: 6492793
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sterol Biosynthesis Inhibition in Pregnant Women Taking Prescription Medications.
    Genaro-Mattos TC; Klingelsmith KB; Allen LB; Anderson A; Tallman KA; Porter NA; Korade Z; Mirnics K
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):848-857. PubMed ID: 33860207
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The N-Terminus of Human Sulfotransferase 2B1b─a Sterol-Sensing Allosteric Site.
    Cook I; Leyh TS
    Biochemistry; 2022 May; 61(10):843-855. PubMed ID: 35523209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).
    Huang SS; Liu IH; Chen CL; Chang JM; Johnson FE; Huang JS
    J Cell Biochem; 2017 Jun; 118(6):1387-1400. PubMed ID: 27862220
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.
    Pullinger CR; Eng C; Salen G; Shefer S; Batta AK; Erickson SK; Verhagen A; Rivera CR; Mulvihill SJ; Malloy MJ; Kane JP
    J Clin Invest; 2002 Jul; 110(1):109-17. PubMed ID: 12093894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver.
    Axelson M; Angelin B; Hillebrant CG; Reihnér E; Einarsson C
    Biochim Biophys Acta; 1998 Nov; 1394(2-3):153-7. PubMed ID: 9795194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J; Angelin B; Einarsson K
    J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man.
    Axelson M; Björkhem I; Reihnér E; Einarsson K
    FEBS Lett; 1991 Jun; 284(2):216-8. PubMed ID: 2060639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
    Reihnér E; Angelin B; Rudling M; Ewerth S; Björkhem I; Einarsson K
    J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B; Ewerth S; Einarsson K
    J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.